Allergan Plc
(NYSE : AGN)

( )
AGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan Plc -0.05%198.712.9%$529.14m
TEVATeva Pharmaceutical Industries Ltd. -1.04%13.312.0%$302.42m
ZTSZoetis, Inc. -0.37%143.531.9%$287.15m
MYLMylan NV 0.12%20.933.2%$111.49m
BBIOBridgeBio Pharma, Inc. -0.51%34.990.0%$11.51m
RDYDr. Reddy's Laboratories Ltd. -1.75%44.852.0%$10.19m
TXMDTherapeuticsMD, Inc. -10.42%2.1522.2%$7.59m
ABEOAbeona Therapeutics, Inc. -1.47%4.024.5%$6.88m
VBIVVBI Vaccines, Inc. 0.00%1.500.2%$5.54m
TAROTaro Pharmaceutical Industries Ltd. 0.53%72.896.5%$3.05m
CPHIChina Pharma Holdings, Inc. -0.19%0.430.1%$2.20m
LFVNLifeVantage Corp. -2.69%15.203.3%$1.61m
KINKindred Biosciences, Inc. 0.43%9.440.3%$0.78m
COCPCocrystal Pharma, Inc. -0.69%0.520.0%$0.37m
JAGXJaguar Health, Inc. 1.71%0.702.2%$0.22m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.